Japan
· Delayed Price · Currency is JPY Kobayashi Pharmaceutical Company Description
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan and internationally.
The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese medicine; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air freshener, lens cleaner, cooling gel sheets, and oral hygiene products.
It also manufactures and sells pharmaceuticals, cosmetics, and health foods; and manufactures and sells synthetic resin products; markets nutritional supplements and skin care products through mail orders; and sells skincare products, daily necessities, and health foods, as well as manufactures body warmers.
In addition, the company engages in transportation, real estate management, and advertising planning and production businesses; manufacture of sanitary and paper products; and asset management.
Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
| Country | Japan |
| Founded | 1886 |
| Industry | Household & Personal Products |
| Sector | Consumer Staples |
| Employees | 3,534 |
| CEO | Satoshi Yamane |
Contact Details
Address: KDX Kobayashi Doshomachi Building Osaka, 541-0045 Japan | |
| Phone | 81 6 6231 1144 |
| Website | kobayashi.co.jp |
Stock Details
| Ticker Symbol | 4967 |
| Exchange | Tokyo Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | JPY |
| ISIN Number | JP3301100008 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Satoshi Yamane | Chief Executive Officer |
| Yumi Nakagawa | Chief Financial Officer |